A SARS-CoV-2 RBD vaccine fused to the chemokine MIP-3α elicits sustained murine antibody responses over 12 months and enhanced lung T-cell responses
Article in Frontiers in Immunology (February 2024)
The most recent citing publications are shown below. View all 75 publications that cite this research output on Dimensions.
Article in Frontiers in Immunology (February 2024)
Book chapter (January 2024)
Article in Advanced Science (October 2023)